Background: The economic consequences of environmental tobacco smoke (ETS) have been simulated using models. We examined the individual-level association between ETS exposure and medical costs among Japanese nonsmoking women.
INTRODUCTION
Exposure to environmental tobacco smoke (ETS), also known as secondhand smoke, passive smoking, and involuntary smoking, is a risk factor for mortality 1, 2 and morbidity from many diseases, including lung cancer 3, 4 and coronary heart disease. 5, 6 ETS exposure accounts for 11% of all tobaccorelated deaths. 7 Öberg et al 8 reported that 1.0% of worldwide mortality is attributable to ETS. Public health concern is therefore elevated because diseases attributable to ETS are occurring among nonsmokers, and the resulting increase in mortality and morbidity is involuntary.
Medical expenditures are higher for active smokers than for nonsmokers, [9] [10] [11] [12] [13] [14] [15] and ETS is a risk factor for many of the same diseases caused by active smoking. [3] [4] [5] [6] These facts naturally lead us to question whether ETS increases medical expenditures. Little is known, however, of the relationship between ETS exposure and medical expenditures among adults. Previous studies estimated the economic burden attributable to ETS by combining ETS-attributable incidence of diseases and medical costs associated with those diseases. [16] [17] [18] [19] [20] [21] The results were obtained from simulations using economic models and did not necessarily reflect the real world.
Japanese women have the highest ETS exposure among the 7 major industrialized nations. 22 The World Health Organization (WHO) has calculated that 49% to 62% of Japanese women are exposed to ETS. 22 WHO also reported that 42% of Japanese men smoked in 2006, which was the highest rate among the 7 nations. However, the prevalence of smoking among Japanese women was 13% in 2006-the lowest among the 7 nations.
We used individual-level observations of a single cohort of Japanese women to examine differences in direct medical expenditure among nonsmokers and those highly exposed, moderately exposed, and not exposed to ETS.
METHODS Study design and setting
We used a prospective cohort design. The data were derived from the Ohsaki Cohort Study, the details of which have been reported elsewhere. 23 In brief, this study started in 1994. We conducted a questionnaire survey of National Health Insurance (NHI) beneficiaries aged 40 to 79 years who lived in the catchment area of Ohsaki Public Health Center (Miyagi Prefecture) between October and December 1994. Japan has a universal healthcare system, and the NHI system is operated by local governments, enrolls individuals (eg, farmers, the self-employed, the retired, part-time workers, and their families) not covered by Employees' Health Insurance, and pays for almost all medical services and medications.
This survey used a self-administered questionnaire on various health-related lifestyle factors. Among 54 996 eligible beneficiaries, 52 029 (95%) responded. We prospectively collected claims data (directly from the Miyagi NHI Organizations) on medical expenditures (inpatient and outpatient), insurance status, and survival status for all participants in the cohort during the study period of January 1995 through December 2007. This study was approved by the Ethics Committee of Kyoto University Graduate School of Medicine (Number E1059).
Study population
Among the 52 029 participants in the baseline survey in 1994, we excluded 774 who died or withdrew from NHI before January 1, 1995. Of the 51 255 remaining participants, we selected all female lifelong nonsmokers (n = 17 803), who were identified by the question, "Are you a current smoker, a former smoker, or have never smoked?" All participants who selected the third option were classified as lifelong nonsmokers. We excluded women who provided incomplete information on ETS exposure at home (n = 634); those who made a proxy complete the baseline questionnaire (to avoid incorrect assessments made by a proxy; n = 2081); those exposed to ETS at work 3 or more days per week (n = 4538); those who were divorced or widowed (to avoid underestimating past ETS exposure at home; n = 1926); those who had left their job (to avoid underestimating past ETS exposure at work; n = 3284); those who died or withdrew in 1995, ie, the first follow-up year (to avoid extremely high or low monthly expenditures; n = 215); and those with a history of cancer, myocardial infarction, or stroke (n = 255). A total of 4870 women remained for analysis.
Assessment of ETS exposure
We conducted a baseline questionnaire survey of all participants. The item on ETS exposure at home was worded, "How often are you exposed to environmental tobacco smoke at home?" Participants were asked to choose 1 of 5 options: almost every day, 3 to 4 days per week, 1 to 2 days per week, less than once per week, and rarely. For our analyses, we defined household high-level exposure to ETS as the first and second options, moderate-level exposure as the third and fourth options, and no exposure as the fifth option.
Data analysis
With regard to baseline characteristics, differences between the 3 groups were examined using 1-way analysis of variance for duration of follow-up and the chi-square test for the other variables. The Fisher exact test was used when expected cell counts were less than 5.
The primary outcome was total (ie, inpatient plus outpatient care) average monthly medical expenditure per capita, because total expenditures attributable to ETS exposure can be considered to impose an economic burden on society. Total average monthly expenditure for each woman was calculated by dividing the accumulated expenditures through follow-up by number of months observed. A similar approach has been used in the econometric literature to assess medical expenditures related to smoking. 9 In addition to total expenditure, we calculated and compared medical expenditures for inpatient and outpatient care. Outpatient expenditure included costs for drugs dispensed at pharmacies.
ETS exposure can cause fatal diseases, which incur considerable medical expenditures in the terminal phase. 24 Calculating average monthly expenditure incurred by a mixed population of survivors and nonsurvivors creates a bias against the group with the higher mortality risk. Hence, we performed separate analyses for survivors and nonsurvivors.
Cost data are typically skewed to the right. Therefore, generalized linear models with a gamma distribution and loglink function were used to examine the relationship between medical expenditures and ETS exposure, after controlling for other variables. 25 Gamma regression models have been shown to be multiplicative. Exponentiated coefficients were interpreted as cost ratio relative to the referent group. Gamma regression models removed zero-valued outcomes in the statistical software. Because the proportion of women with zero data for total and outpatient expenditures was small (6, 3, and 2 unexposed, moderately exposed, and highly exposed women, respectively), we added ¥1 to those who had zero expenditures to simplify the analyses. In contrast, inpatient expenditure data contained many zero-valued observations. Hence, we used logistic models to estimate the odds of any inpatient service use and then analyzed inpatient expenditures incurred only by women who had 1 or more hospitalizations.
Crude medical expenditures for moderately exposed and highly exposed women were compared with expenditures for unexposed women, which was used as the referent group. Then, analyses were age-adjusted (age strata: 40-49, 50-59, 60-69, and 70-79 years at baseline survey in 1994) and fully adjusted. The following variables were entered into the fully adjusted model: age stratum, body mass index (weight in kilograms divided by height in meters squared; <18.5, 18.5-24.9, ≥25.0), 11, 26 alcohol drinking status (never, former, currently drinking <3 go-a traditional Japanese unit of measure equal to 180 mL of Japanese sake and containing 22.8 g of ethanol-per week, currently drinking ≥3 go per week), tertiles of daily dietary energy intake (≤1163, 1163-1440, >1440 kcal/day), time spent walking per day (<30, 30-60, ≥60 minutes), 27 self-rated health (good, mediocre, poor), marital status (married, unmarried), current job status (employed, unemployed), and education (≤9, >9 years). Time spent walking represented physical activity level.
The final multivariable model was similar to the fully adjusted model but included the interaction between exposure (28) 401 (29) 474 (32) 41 (28) 21 (27) (2) 31 (2) 32 (2) 8 (5) 4 (5) 0 (0) Current, <3 go per week c 249 (15) 263 (19) 272 (18) 13 (9) 11 (14) 10 ( (3) 38 (3) 39 (3) 1 (1) 1 (1) level and age stratum. This model with interaction enabled us to assess different ETS-attributable economic consequences by age stratum. Whether there were differences due to ETS exposure level was determined by cost ratios for each age stratum. The following SAS statements were used to calculate cost ratios of medical expenditures in the model with the interaction. proc genmod data = ohsaki; class ets age bmi alcohol diet walking healthrating marriage job education; model expenditure = ets age bmi alcohol diet walking healthrating marriage job education ets*age / dist=gamma link=log type3; run; Median total monthly expenditures per capita and interquartile ranges are presented for each age stratum. All observed expenditures were not inflation-adjusted or discounted, because medical fees were revised slightly (−3.16% to 0.80%) every 2 years during the study period. A 2-sided test was used, and a P-value <0.05 was considered statistically significant. All expenditures are expressed as Japanese yen (¥107 = US$1 according to the purchasing power parity rate from the Organisation for Economic Cooperation and Development National Accounts database in 2011). All statistical analyses were performed using IBM SPSS version 18 (SPSS Inc., Chicago, IL, USA) and SAS version 9.2 (SAS Institute Inc., Cary, NC, USA). Table 1 shows the baseline characteristics of women not exposed, moderately exposed, and highly exposed to ETS by survival status. The age stratum 60 to 69 years had the most women (n = 1664), and the age stratum 70 to 79 years had the fewest women (n = 507). Among all women (n = 4870), 1836 (38%) were not exposed to ETS at home, 1448 (30%) were moderately exposed, and 1586 (33%) were highly exposed. Among survivors, the largest groups in the age strata 40 to 49, 50 to 59, 60 to 69, and 70 to 79 years were women who were highly exposed, moderately exposed, unexposed, and unexposed, respectively.
RESULTS

Participant characteristics
A total of 318 (7%) women died during the follow-up period; 22 (2%) died among 1258 women aged 40 to 49, and 100 (20%) died among 507 women aged 70 to 79. Among survivors, mean follow-up was 135 months; among nonsurvivors, mean follow-up was 93 months. Among survivors, there were significant differences in time spent walking and the proportion of married women among the 3 groups.
Medical expenditures for survivors
Median total monthly medical expenditures per capita ranged from ¥5900 (age stratum 40-49) to ¥29 900 (age stratum 70-79) among survivors ( Table 2) . Crude, age-adjusted, and fully adjusted (the model without the interaction) cost ratios for moderately exposed and highly exposed survivors, as compared with unexposed survivors, are shown in Table 2 . Cost ratios of total (ie, inpatient plus outpatient care), inpatient and outpatient expenditures, and odds ratios of hospitalization were calculated for moderately exposed and highly exposed women in relation to unexposed women, which was used as the referent category.
We found significant differences in some crude total, inpatient, and outpatient expenditures associated with ETS exposure. For example, crude total expenditures were lower for moderately exposed and highly exposed women than for unexposed women. In contrast, we found no significant difference in age-adjusted or fully adjusted total expenditures, regardless of exposure, although age-adjusted and fully adjusted inpatient expenditures were higher for highly exposed women than for unexposed women.
There were significant differences in the fully adjusted model with the interaction term between exposure level and age stratum (Table 2) . Total expenditure for age stratum 70 to 79 years was higher for highly exposed women than for unexposed women after adjusting for other variables (cost ratio, 1.43; 95% CI, 1.13-1.81). The difference in total expenditure between unexposed and moderately exposed women was not significant.
When inpatient and outpatient care were analyzed separately, inpatient expenditure was higher for highly exposed women than for unexposed women (cost ratio, 1.94; 95% CI, 1.38-2.74), although there was no significant association between probability of hospitalization and exposure level. We found no difference in adjusted outpatient expenditures for age stratum 70 to 79 years, regardless of exposure.
In the age strata 40 to 49, 50 to 59, and 60 to 69 years, total, inpatient, and outpatient medical expenditures did not significantly differ, regardless of exposure (Table 2) . However, inpatient expenditures tended to be higher for highly exposed women than for unexposed women among all these strata.
Medical expenditures for nonsurvivors
Median total monthly medical expenditures per capita ranged from ¥48 200 (age stratum 40-49) to ¥69 500 (age stratum 60-69) among nonsurvivors (Table 3) .
Crude, age-adjusted, and fully adjusted (the model without the interaction) cost ratios for moderately exposed and highly exposed nonsurvivors, as compared with unexposed nonsurvivors, are shown in Table 3 . Crude, age-adjusted, and fully adjusted total expenditures were lower for moderately exposed nonsurvivors than for unexposed nonsurvivors. Table 3 also shows cost ratios of medical expenditures for nonsurvivors in the fully adjusted model with the interaction between exposure level and age stratum. In all age strata, including age stratum 70 to 79 years, we found no significant difference in total expenditure regardless of exposure, although outpatient expenditures for the age strata 50 to 59 and 60 to 69 years were lower for moderately exposed nonsurvivors than for unexposed nonsurvivors.
DISCUSSION
To calculate expenditures attributable to ETS, we analyzed medical expenditures incurred by female nonsmokers who were not exposed, moderately exposed, and highly exposed to ETS in the home. Among highly exposed survivors aged 70 to 79 years, we found that a substantial increase in total medical expenditure was possibly attributable to ETS exposure at home. This excess expenditure suggests a significant agespecific association between ETS exposure and total medical expenditure.
The association of ETS exposure with economic impact is consistent with known clinical relationships and provides an explanation for the economic burden. Although our significant findings regarding total expenditures are limited to older survivors, they support the results of previous simulation studies [16] [17] [18] [19] [20] [21] that estimated the economic burden caused by ETS-attributable diseases at the national, regional, and state levels rather than the individual level.
Interpretation of findings
High ETS exposure resulted in significantly higher inpatient but not outpatient expenditures among survivors aged 70 to 79 years, which suggests that the excess total expenditure arose from treatment for serious but nonfatal diseases rather than from treatment for relatively minor disorders.
ETS exposure significantly increased total medical expenditures only among survivors aged 70 to 79 years. One plausible explanation for this result is that it takes many years to produce a significant difference in total medical expenditures between unexposed and highly exposed adults, because the harm of ETS is subtle in comparison to active smoking. Another likely explanation is that diseases result in higher morbidity among older versus younger adults. Notably, among women aged 40 to 69 years, highly exposed women tended to incur higher inpatient expenditures than unexposed women, which suggests that serious but nonfatal diseases attributable to ETS are already present among highly exposed women in these age strata.
In contrast to survivors, we found no significant agespecific association between total medical expenditures incurred by nonsurvivors and ETS exposure, perhaps because ETS exposure does not increase costs of therapy for fatal diseases, although exposure increases the incidence of such diseases. In contrast to our findings among nonsurvivors, ETS-attributable excess total expenditures among survivors may arise from the accumulation of excess morbidities from nonfatal and near-fatal diseases.
The results for nonsurvivors in age strata 50 to 59 and 60 to 69 years showed that moderately exposed nonsurvivors incurred lower outpatient expenditures as compared with unexposed nonsurvivors, possibly because relatively low doses of toxins inhaled from ETS are pathophysiologically sufficient to elicit a strong acute effect on the cardiovascular system, whereas lung cancer is caused by long-term exposure. 28 This evidence suggests that ETS exposure causes rapid onset of coronary heart disease and subsequent death in these age strata, which may account for the lower monthly outpatient expenditure.
Strengths and limitations of the study Our study has several advantages as compared with previous studies. To the best of our knowledge, this is the first study using directly observed long-term individual-level health insurance records to show a significant association between ETS exposure and medical expenditures among adults. Previous studies estimated population-level ETS-attributable expenditures by using economic models of mixed results from multiple databases, such as the published literature and macrodata on ETS exposure, increased morbidity, and medical costs. [16] [17] [18] [19] [20] [21] We showed the individual-level economic burden imposed by ETS exposure by means of comparison within a single cohort.
Furthermore, we followed a large cohort for a long period. The expenditures in our analyses were accurate because we obtained health insurance claims data directly from the Miyagi NHI Organizations, which included information on almost all available medical services. Long-term observation allowed average monthly expenditure to be unaffected by short-term incidental use of medical services.
Our study has several limitations. First, assessment of ETS exposure was based on a questionnaire survey. Misclassification of exposure status is a concern in studies that use only questionnaires. Quantitative information on ETS exposure is less reliable in questionnaires, but information on whether exposure is heavy or light is relatively reliable. 29, 30 Second, the questionnaire in our study focused on ETS exposure at 1 time point, as we assumed that exposure status at baseline was correlated with past exposure. To ensure the correctness of this assumption, we excluded women with a change in job status or marital status during their lifetime. Nevertheless, further research based on long-term continuous ETS exposure measurement is required. Third, all medical expenditures were included in our analysis. There were no available cost data for specific diseases such as lung cancer and coronary heart disease. However, diseases attributable to ETS exposure range from life-threatening diseases to relatively minor disorders (eg, respiratory tract symptoms). 31 This is similar to active smoking, which has been reported to Economic Burden of Household Exposure to ETSbe relevant to many diseases, including major smoking-related diseases. 32 Previous studies of the association between active smoking and medical expenditures have also addressed overall disease burden. 9, 10 Furthermore, if we analyzed expenditures for specific diseases that were strongly associated with ETS exposure, we might also find significant relationships between ETS exposure and total expenditures for younger women. Future studies of real-world medical expenditures for diseases strongly associated with ETS exposure may be needed to verify the results of previous studies that simulated the excess costs attributable to ETS by combining ETS-attributable diseases and associated medical costs. Finally, long-term care (LTC) insurance claims data were not available. Japan has a LTC insurance system that supports elderly adults living at home or in nursing-care facilities. We believe that women that incur more medical expenditures for treatment of diseases due to ETS exposure may also use more LTC services than women unexposed to ETS.
We examined household ETS exposure because previous cohort studies of the health effects of ETS focused on ETS exposure at home or at work. 1, 2, 5 How applicable are our results to ETS exposure outside the home? Considerable evidence of increased mortality and morbidity related to ETS exposure has also been obtained from exposure in workplaces and public places. 4, 5, 33 We believe that ETS exposure in settings other than the home also increases medical expenditures. Medical expenditures attributable to ETS exposure in the workplace and other settings need to be explored.
This study analyzed the self-employed, part-time workers, the unemployed, and their families. These groups may spend more time at home than corporate employees, who are covered by Employees' Health Insurance. Thus, the effects of household ETS might be more severe in the present study population than in corporate employees and their families.
Conclusions
We found that severe household ETS exposure results in excess total medical expenditures. Surviving female nonsmokers aged 70 to 79 years who were highly exposed to ETS at home incurred significantly higher total medical expenditures than those living in smoke-free households. The present study provides information on the economic burden of ETS, although significant findings regarding total expenditure are limited to surviving older women. This information should help policymakers to develop strategies that reduce secondhand smoke and hasten the economically attractive goal of eliminating ETS. Further research is required to examine the association between accumulated ETS exposure and medical expenditure.
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